Sharepoint Solutions
PRODUCTS
-
ProPharma has built the world’s leading and first full-service global solution dedicated to Advertising & Promotional Review.
-
It’s about time.
Modern ePRO/eCOA.
Solved.Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
-
Every modern town or city has a wastewater collection system of some type. The wastewater collection system is the conduit for used water, both sanitary and graywater (relatively clean, including stormwater), which initiates at the individual homes and businesses in the community. A primary part of the wastewater collection system is a number of “wet wells” that are used as wastewater collection points, or intercepts, from community neighborhoods. Often, lift stations, complete with large electric waste pumps, are used to keep the water moving to the city’s wastewater treatment plant.
-
An optimized and effective Contamination Control Strategy (CCS) helps you organization spend less time cleaning and more time manufacturing. Ecolab Life Sciences experts are dedicated to helping you drive the best possible strategy to meet and exceed the GMO Annex 1 CCS requirements.
-
Ergomed’s Risk-Based Clinical Monitoring and Source Data Verification Approach for Data Integrity
Ergomed ensures the highest data integrity and patient safety standards through our risk-based clinical monitoring and Source Data Verification (SDV) practices. SDV is a critical process in clinical trials that ensures the data collected are accurate, complete, and verifiable against the source documents. We compare data entered into case report forms or electronic data capture systems with the source data to confirm their accuracy and reliability.
WHITE PAPERS AND CASE STUDIES
-
The Evolution Of SDV, SDR, And RBQM In Clinical Trial Data Quality
Explore the inefficiency of complete SDV and how the adoption of technologies like centralized monitoring, remote SDR, and targeted SDV can enhance data integrity and cost-effectiveness.
-
Microbial Challenge In-Use Studies
Learn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.
-
Mobile Lab For A Large Pharma Client
Completed in 2021, learn how this custom BSL-3 mobile laboratory received PHAC approval and ensured a secure environment for PPD powder-related MTech development work.
-
Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer
Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
How To Manage A Drug Product In A Medical Device Environment
Discover how ProPharma successfully ensured GMP and GDP compliance for a drug product within a medical device environment.
-
Enabling CDMOs To Focus On Core Priorities
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
Relieving The Strain Of Publishing During Regulatory Registration
Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.
-
How Syneos Health Tackles Protocol Complexities
Explore solutions employed by Syneos Health, a global contract research organization, to optimize Phase IIV clinical trials, particularly under a complex adaptive trial protocol.
-
Advancing Oncology Innovation With Adaptive Trial Designs
When a biopharmaceutical company developing a novel therapy for solid tumor cancers became concerned with rapid over-enrollment from within a single region, they employed a CRO for assistance.
-
How A CDMO Gained 40%+ Efficiency By Generating Automated APQRs
Discover how a CDMO's mounting challenges with manual product quality review (PQR) processes were resolved through the implementation of a next-generation cloud-based solution.
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Navigating The Complexities Of Pre-Filled Syringe Manufacturing
Drawing on our extensive expertise in sterile injectables (SI), here, we highlight practical strategies and proven solutions designed to help navigate challenges and support the reliable, scalable production of high-quality PFS therapies for patients worldwide.
NEWS
-
Merck To Acquire US Biopharma Company SpringWorks Therapeutics To Accelerate Sustainable Growth Of Healthcare Business4/28/2025
Merck, a leading science and technology company, and SpringWorks Therapeutics, Inc., a Stamford, Connecticut-based commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the companies have entered into a definitive agreement for Merck to acquire SpringWorks.
-
Axim Biotechnologies Files Pre-Submission With FDA For CLIA Waiver Pathway On Lactoferrin Point-Of-Care Diagnostic Test6/24/2025
Axim Biotechnologies, Inc. a leading developer of rapid diagnostic testing for ocular and systemic conditions, today announced that it has filed a Pre-Submission (Pre-Sub Q) with the U.S. Food and Drug Administration (FDA) as the first formal step in seeking a Clinical Laboratory Improvement Amendments (CLIA) Waiver for its rapid, point-of-care Lactoferrin diagnostic test (TearScan Lf).
-
Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver7/2/2025
Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.
-
Higgins, Timmons Introduce Legislation To Repeal EPA Rule On Chemical Manufacturing3/11/2025
Congressman Clay Higgins (R-LA) and Congressman William Timmons (R-SC) introduced legislation to repeal the U.S. Environmental Protection Agency’s (EPA) final procedural rule for new chemical reviews under the Toxic Substances Control Act (TSCA).
-
Study To Determine Most Effective PFAS Treatments For High-Risk Homes3/2/2026
Research to fill key knowledge gaps on the effectiveness of household water treatment systems for PFAS and other fluorinated organic compounds is under way under the direction of Assistant Professor Dr. Riley Mulhern of the University of Colorado Boulder.